Citation: Ka. Sepkowitz, EFFECT OF PROPHYLAXIS ON THE CLINICAL MANIFESTATIONS OF AIDS-RELATED OPPORTUNISTIC INFECTIONS, Clinical infectious diseases, 26(4), 1998, pp. 806-810
Authors:
SEPKOWITZ KA
HELCL J
CASTKOVA J
BENES C
DEHOVITZ JA
Citation: Ka. Sepkowitz et al., CONTROL OF HEPATITIS-B AMONG HEALTH-CARE WORKERS IN THE CZECH-REPUBLIC, Infection control and hospital epidemiology, 19(9), 1998, pp. 31-31
Authors:
SEPKOWITZ KA
RIVERA P
LOUTHER J
LIM S
PRYOR B
Citation: Ka. Sepkowitz et al., POSTEXPOSURE PROPHYLAXIS FOR HUMAN-IMMUNODEFICIENCY-VIRUS - FREQUENCYOF INITIATION AND COMPLETION OF NEWLY RECOMMENDED REGIMEN, Infection control and hospital epidemiology, 19(7), 1998, pp. 506-508
Authors:
LOUTHER J
FELDMAN J
RIVERA P
VILLA N
DEHOVITZ J
SEPKOWITZ KA
Citation: J. Louther et al., HEPATITIS-B VACCINATION PROGRAM AT A NEW-YORK-CITY HOSPITAL - SEROPREVALENCE, SEROCONVERSION, AND DECLINATION, American journal of infection control, 26(4), 1998, pp. 423-427
Authors:
LOUTHER J
RIVERA P
FELDMAN J
VILLA N
DEHOVITZ J
SEPKOWITZ KA
Citation: J. Louther et al., RISK OF TUBERCULIN CONVERSION ACCORDING TO OCCUPATION AMONG HEALTH-CARE WORKERS AT A NEW-YORK-CITY HOSPITAL, American journal of respiratory and critical care medicine, 156(1), 1997, pp. 201-205
Authors:
MURPHY M
BROWN AE
SEPKOWITZ KA
BERNARD EM
KIEHN TE
ARMSTRONG D
Citation: M. Murphy et al., FLUOROQUINOLONE PROPHYLAXIS FOR THE PREVENTION OF BACTERIAL-INFECTIONS IN PATIENTS WITH CANCER - IS IT JUSTIFIED, Clinical infectious diseases, 25(2), 1997, pp. 346-347
Authors:
MANNHEIMER SB
SEPKOWITZ KA
STOECKLE M
FRIEDMAN CR
HAFNER A
RILEY LW
Citation: Sb. Mannheimer et al., RISK-FACTORS AND OUTCOME OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH SPORADIC MULTIDRUG-RESISTANT TUBERCULOSIS IN NEW-YORK-CITY, The international journal of tuberculosis and lung disease, 1(4), 1997, pp. 319-325
Authors:
RIVERA P
LOUTHER J
MOHR J
CAMPBELL A
DEHOVITZ J
SEPKOWITZ KA
Citation: P. Rivera et al., DOES A CHEAPER MASK SAVE MONEY - THE COST OF IMPLEMENTING A RESPIRATORY PERSONAL PROTECTIVE EQUIPMENT PROGRAM, Infection control and hospital epidemiology, 18(1), 1997, pp. 24-27
Authors:
MURPHY M
ARMSTRONG D
SEPKOWITZ KA
AHKAMI RN
MYSKOWSKI PL
Citation: M. Murphy et al., REGRESSION OF AIDS-RELATED KAPOSIS-SARCOMA FOLLOWING TREATMENT WITH AN HIV-1 PROTEASE INHIBITOR, AIDS, 11(2), 1997, pp. 261-262
Authors:
MERRICK ST
SEPKOWITZ KA
WALSH J
DAMSON L
MCKINLEY P
JACOBS JL
Citation: St. Merrick et al., COMPARISON OF INDUCED VERSUS EXPECTORATED SPUTUM FOR DIAGNOSIS OF PULMONARY TUBERCULOSIS BY ACID-FAST SMEAR, American journal of infection control, 25(6), 1997, pp. 463-466
Authors:
SEPKOWITZ KA
FELDMAN J
LOUTHER J
RIVERA P
VILLA N
DEHOVITZ J
Citation: Ka. Sepkowitz et al., BENEFIT OF 2-STEP PPD TESTING OF NEW EMPLOYEES AT A NEW-YORK-CITY HOSPITAL, American journal of infection control, 25(3), 1997, pp. 283-286
Citation: Sc. Ball et al., THALIDOMIDE FOR TREATMENT OF ORAL APHTHOUS ULCERS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS - CASE-REPORT AND REVIEW, The American journal of gastroenterology, 92(1), 1997, pp. 169-170
Authors:
HENNING KJ
WHITE M
SEPKOWITZ KA
MONTES D
ARMSTRONG D
Citation: Kj. Henning et al., NATIONAL SURVEY OF IMMUNIZATION PRACTICES AMONG ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) CENTERS, Clinical infectious diseases, 23(4), 1996, pp. 62-62
Authors:
STRACHER AR
MERRICK ST
SEPKOWITZ KA
SOAVE R
Citation: Ar. Stracher et al., LISTERIA-MONOCYTOGENES BRAIN-ABSCESS IN A PATIENT WITH HIV-INFECTION, Infectious diseases in clinical practice, 5(4), 1996, pp. 282-284
Citation: Ka. Sepkowitz, TUBERCULIN SKIN TESTING AND THE HEALTH-CARE WORKER - LESSONS OF THE PROPHIT SURVEY, Tubercle and lung disease, 77(1), 1996, pp. 81-85
Authors:
NOSANCHUK JD
SEPKOWITZ KA
PEARSE RN
WHITE MH
NIMER SD
ARMSTRONG D
Citation: Jd. Nosanchuk et al., INFECTIOUS COMPLICATIONS OF AUTOLOGOUS BONE-MARROW AND PERIPHERAL STEM-CELL TRANSPLANTATION FOR REFRACTORY LEUKEMIA AND LYMPHOMA, Bone marrow transplantation, 18(2), 1996, pp. 355-359